Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammed F Alqanbar"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 14, Iss 6, Pp BC05-BC09 (2020)
ABSTRACT Introduction: Ischemic Heart Diseases (IHD) is one of the most common causes of death worldwide. Myocardial impairment is an imbalance between coronary blood flow and myocardial needs which result in circulatory changes. Cardiovascular Dise
Externí odkaz:
https://doaj.org/article/eed8d209024d45f086371d04b24862b8
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 60, Iss 4, Pp 475-480 (2017)
Background: The human epidermal growth factor receptor 2(HER2) proto-oncogene is overexpressed or amplified in approximately 15%–25% of invasive breast cancers. Approximately 35% of HER2-amplified breast cancers have coamplification of the topoisom
Externí odkaz:
https://doaj.org/article/0325af683c0641d0bd8aa591fb4c859c
Autor:
Mohammed F. Aljawad, Abdul Hussein M. Al Faisal, Mohammed F. Alqanbar, Phillip A. Wilmarth, Basima Q. Hassan
Publikováno v:
Proteomics. Clinical applicationsREFERENCES.
Cervical cancer is a common cancer in women caused by high-risk human papillomavirus (Hr-HPV). Many potential biomarkers have been proposed for precancerous lesions and cancer diagnosis and some of these markers studied for prognosis. This study dete
Publikováno v:
Journal of Contemporary Medical Sciences. 5:254-257
Objectives: The aim of this study was to investigate the prevalence of gastric premalignant changes as gastric atrophy, intestinal metaplasia and dysplastic changes in patients underwent esophagogastroduodenoscopy in three health institutions in Karb
Autor:
Rasha Abd Alraouf, Neama, Manal A, Habib, Sahira A, Ali, Ali H, Al-Khafaji, Mohammed F, Alqanbar
Publikováno v:
Indian journal of pathologymicrobiology. 60(4)
The human epidermal growth factor receptor 2(HER2) proto-oncogene is overexpressed or amplified in approximately 15%-25% of invasive breast cancers. Approximately 35% of HER2-amplified breast cancers have coamplification of the topoisomerase II-alpha